IL Science Balance Sheet Health
Financial Health criteria checks 1/6
IL Science has a total shareholder equity of ₩21.1B and total debt of ₩66.6B, which brings its debt-to-equity ratio to 315.5%. Its total assets and total liabilities are ₩114.6B and ₩93.5B respectively.
Key information
315.5%
Debt to equity ratio
₩66.64b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩4.54b |
| Equity | ₩21.12b |
| Total liabilities | ₩93.50b |
| Total assets | ₩114.62b |
Financial Position Analysis
Short Term Liabilities: A307180's short term assets (₩30.5B) do not cover its short term liabilities (₩81.2B).
Long Term Liabilities: A307180's short term assets (₩30.5B) exceed its long term liabilities (₩12.3B).
Debt to Equity History and Analysis
Debt Level: A307180's net debt to equity ratio (294%) is considered high.
Reducing Debt: Insufficient data to determine if A307180's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A307180 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A307180 has less than a year of cash runway if free cash flow continues to grow at historical rates of 14.7% each year.